Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
T cell hybrid immunity against SARS-CoV-2 in children: a longitudinal study.
Journal: EBioMedicine
Published: January 26, 2024
Immunogenicity and safety of Sinovac-CoronaVac booster vaccinations in 12-17- year-olds with clinically significant reactions from Pfizer-BNT162b2 vaccination.
Journal: Vaccine
Published: August 26, 2023
Potent pan huACE2-dependent sarbecovirus neutralizing monoclonal antibodies isolated from a BNT162b2-vaccinated SARS survivor.
Journal: Science advances
Published: July 26, 2023
BNT162b2 vaccine induced variant-specific immunity, safety and risk of Omicron breakthrough infection in children aged 5 to 11 years: a cohort study.
Journal: Scientific reports
Published: May 12, 2023
Clinical Course, Immunogenicity, and Efficacy of BNT162b2 mRNA Vaccination Against SARS-CoV-2 Infection in Liver Transplant Recipients.
Journal: Transplantation direct
Published: April 22, 2023
COVID-19 mRNA vaccine immunogenicity decay and breakthrough illness in adolescents and young adults with childhood-onset rheumatic diseases.
Journal: Rheumatology (Oxford, England)
Published: September 12, 2022
Early seasonal coronavirus seroconversion did not produce cross-protective SARS-CoV-2 antibodies.
Journal: The Journal of infection
Published: August 11, 2022
SARS-CoV-2 Omicron variant emerged under immune selection.
Journal: Nature microbiology
Published: June 24, 2022
Robust neutralizing antibody response to SARS-CoV-2 mRNA vaccination in adolescents and young adults with childhood-onset rheumatic diseases.
Journal: Rheumatology (Oxford, England)
Published: November 26, 2021
Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose.
Journal: Nature communications
Published: November 22, 2021
Last Updated: 09/26/2026